Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT05401097 |
Title | Ivosidenib or Enasidenib Followed by Azacitidine Plus Venetoclax or Azacitidine Plus Venetoclax Followed by Ivosidenib or Enasidenib for the Treatment of IDH Mutated Acute Myeloid Leukemia in Older Patients. The I-DATA Study |
Recruitment | Not yet recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | Alice Mims |
Indications | |
Therapies |
Azacitidine + Enasidenib + Venetoclax |
Age Groups: | adult | senior |
Covered Countries | USA |